Toll-like receptor 5 (TLR5) expression is also associated with microbial expression, e.g., Salmonella typhimurium flagellin, and activates the innate immune response in BC patients, marking TLR5 as a therapeutic target (Table 1) [15]. The gene discussed is TLR5; the disease is breast cancer.